Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios sophia, s.a. de c.v. - tetracaina clorhidrato - tetracaina clorhidrato....5,00 mg

United States - English - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), tetracaine (unii: 0619f35cgv) (tetracaine - unii:0619f35cgv) - lidocaine 70 mg in 1 g - pliaglis is indicated for use on intact skin in adults to provide topical local analgesia for superficial dermatological procedures such as dermal filler injection, pulsed dye laser therapy, facial laser resurfacing, and laser-assisted tattoo removal. - pliaglis is contraindicated in patients with a known history of sensitivity to lidocaine or tetracaine, local anesthetics of the amide or ester type, or to any other component of the product [see warnings and precautions (5.4) ]. - pliaglis is contraindicated in patients with para-aminobenzoic acid (paba) hypersensitivity. risk summary there are no available data on pliaglis use in pregnant women to determine a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. available data from an epidemiologic study and case series with parenteral lidocaine use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes. published data on tetracain

United States - English - NLM (National Library of Medicine)

oba pharmaceuticals, inc. - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), tetracaine (unii: 0619f35cgv) (tetracaine - unii:0619f35cgv) - pliaglis is indicated for use on intact skin in adults to provide topical local analgesia for superficial dermatological procedures such as dermal filler injection, pulsed dye laser therapy, facial laser resurfacing, and laser-assisted tattoo removal. - pliaglis is contraindicated in patients with a known history of sensitivity to lidocaine or tetracaine, local anesthetics of the amide or ester type, or to any other component of the product [see warnings and precautions (5.4) ]. - pliaglis is contraindicated in patients with para-aminobenzoic acid (paba) hypersensitivity. risk summary there are no available data on pliaglis use in pregnant women to determine a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. available data from an epidemiologic study and case series with parenteral lidocaine use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes. published data on tetracain

United States - English - NLM (National Library of Medicine)

oba pharmaceuticals, inc. - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), tetracaine (unii: 0619f35cgv) (tetracaine - unii:0619f35cgv) - pliaglis is indicated for use on intact skin in adults to provide topical local analgesia for superficial dermatological procedures such as dermal filler injection, pulsed dye laser therapy, facial laser resurfacing, and laser-assisted tattoo removal. - pliaglis is contraindicated in patients with a known history of sensitivity to lidocaine or tetracaine, local anesthetics of the amide or ester type, or to any other component of the product [see warnings and precautions (5.4) ]. - pliaglis is contraindicated in patients with para-aminobenzoic acid (paba) hypersensitivity. risk summary there are no available data on pliaglis use in pregnant women to determine a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. available data from an epidemiologic study and case series with parenteral lidocaine use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes. published data on tetracain

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - phenazone; tetracaine hydrochloride - drops - phenazone 5 %w/w; tetracaine hydrochloride 0.5 %w/w - tetracaine - tetracaine - relief of pain in acute otitis media.

Canada - English - Health Canada

hoechst canada inc. - tetracaine - metered-dose aerosol - 754mg - tetracaine 754mg - dental agents

Canada - English - Health Canada

sanofi canada, inc. - tetracaine hydrochloride - drops - .5% - tetracaine hydrochloride .5% - local anesthetics

Canada - English - Health Canada

sanofi canada, inc. - tetracaine hydrochloride - powder for solution - 20mg - tetracaine hydrochloride 20mg - general anesthetics

Canada - English - Health Canada

medibrands israel (subsidiary of mediline ltd) - tetracaine - cream - 2% - tetracaine 2% - antipruritics and local anesthetics